Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
Public ClinicalTrials.gov record NCT00874302. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Open Label, Randomized, Multicenter Study Evaluating the Safety and Efficacy of 25 mg and 50 mg Doses of Proellex to Assess Recurrence of Symptoms in the Treatment of Symptomatic Uterine Fibroids
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Subjects with symptomatic uterine fibroids will be enrolled and will receive daily oral study medication for 4 months. This will be followed by a 6 month off-drug interval until there is a return of significant symptomatology. If they experience symptoms of a certain severity, the subject will enter a second 4 month treatment cycle and then a follow-up period.
Study identification
- NCT ID
- NCT00874302
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 27, 2014
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Genesis Center for Clinical Research | San Diego | California | 92103 | — |
| Physician Care Clinical Research, LLC | Sarasota | Florida | 34239 | — |
| Atlanta Women's Research Inst. | Atlanta | Georgia | 30342 | — |
| Soapstone Center for Clinical Research | Decatur | Georgia | 30034 | — |
| York Clinical Consulting | Marrero | Louisiana | 70072 | — |
| Female Pelvic Medicine | Grand Rapids | Michigan | 49503 | — |
| Hawthorne Medical Research, Inc. | Winston-Salem | North Carolina | 27103 | — |
| Lyndhurst Gynecologic Associates | Winston-Salem | North Carolina | 27103 | — |
| Clinical Trials of America | Eugene | Oregon | 97408 | — |
| Thomas Jefferson University - Jefferson Center for Women's Medical Specialties | Philadelphia | Pennsylvania | 19107-5127 | — |
| Women's Care Center, PLC Research Memphis Associates | Memphis | Tennessee | 38119 | — |
| Meharry Medical College | Nashville | Tennessee | 37208 | — |
| Willowbend Health & Wellness Associates | Plano | Texas | 75093 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00874302, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 27, 2014 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00874302 live on ClinicalTrials.gov.